Pfizer stock: Covid rally reverses as vaccine makers take on a new variant

shares accident (mRNA) And Pfizer (PFE) shares year-over-year on Friday — after gaining late Thursday on the back of a rebound linked to the updated Covid snapshot.




X



Late Thursday, both companies said their latest Covid booster shots showed promise in lab tests against the leading variant, dubbed “iris,” or EG.5. Moderna also said its booster antibodies are able to counteract the “fornax” variant, or FL 1.5.1.

Iris accounted for more than 17% of sequenced Covid cases in the United States from July 23 to August 5, according to the Centers for Disease Control and Prevention. Fornax has been responsible for less than 9% of cases. But Moderna says it’s rising in some areas of the country.

“Our updated Covid-19 vaccine generates a robust immune response against rapidly spreading EG.5 and FL 1.5.1 strains and reflects our updated vaccine’s ability to counter emerging Covid-19 threats,” Moderna President Stephen Hogg said in a written statement.

In today’s stock market, Moderna stock fell 4.4% to close at 101.62. Pfizer shares rose 0.5%, reversing earlier losses, and closing at 36.66. On Thursday, the two companies’ earnings rose 7.4% and 2.9%.

shares Biotechnology (BNTX), Pfizer’s partner, fell 2.5%, ending the regular session at 110.36, after rising 4.9% on Thursday. novafax (NVAX) rose 3.4% on Thursday, but fell 3.1% to 7.14 on Friday.

Pfizer shares: Covid hospitalizations soar

All companies plan to launch vaccines in September that block omicron’s XBB.1.5 variant. At the time, it was the dominant variant in the United States today, it accounts for nearly 10% of Covid cases, according to the CDC.

The launch could come amid rising hospitalization rates. In the United States, hospitalizations related to Covid have risen by more than 40% from recent lows in June, according to Reuters. However, hospitalization rates are less than 90% of peak levels during the Omicron outbreak in January 2022.

But demand remains essential. Pfizer, BioNTech, and Moderna reported lower sales in the second quarter. Novavax reported a triple-digit percentage increase, although it trimmed its full-year forecast by $100 million. According to the latest data available in May, only 17% of the total US population received an updated booster dose.

And shares of all the Covid vaccine manufacturers have fallen from their peak in 2021.

Right now, Pfizer stock is trapped below the 50-day moving average with an IBD digital relative strength rating of 23. That puts the stock in the bottom quartile of all stocks when it comes to 12-month performance. Moderna stock has an RS rating of less than 12.

Follow Allison Gatlin on Twitter at @employee.

You may also like:

Why this nugget of bad weight loss news isn’t weighing in on Lilly, Novo

How Revance takes a page out of AbbVie’s Botox playbook

Find winning stocks using MarketSmith’s pattern recognition system and custom screens

Best Growth Stocks to Buy and Watch: See updates to IBD stock listings

Find the best long-term investments with IBD’s long-term leaders

Related Posts

Man Has DNA Test Done on Son Who ‘Doesn’t Look Like’ Him, Wife Gathers Family upon Receiving Results

For five years, Emily and Mark built a life filled with love, laughter, and the shared joy of raising their son, Daniel. Their home was a haven of happiness, a…

Read more

First Daughters Sasha and Malia Obama Were Spotted Attending Drake’s After-Party

Sasha and Malia Obama, who spent their childhood in the White House, have now transitioned into young women, navigating their lives outside the presidential residence.Their recent appearance at an after-party…

Read more

Neighbor discovers unidentified object in backyard causing confusion on the internet

Sometimes, when we come across strange things in our lives, we turn to the internet for answers. And when a woman woke up one morning and found something peculiar in…

Read more

They Tore Mom Down When Writing Her Obituary

The obituary for Kathleen Dehmlow, published by *The Redwood Falls Gazette*, quickly drew public attention and outrage due to its surprising content. While it started as a typical tribute, the…

Read more

Marry the girl who has no clue what this is!

Answer: This is a high heel pad.

Read more

The Oscar-winning actor from “An Officer and a Gentleman” has died at the age of 87.

Louis Gossett Jr., the trailblazing actor known for his iconic roles in *An Officer and a Gentleman* and *Roots*, has passed away at the age of 87. He made history…

Read more

Leave a Reply

Your email address will not be published. Required fields are marked *